Sign in to continue:

Sunday, July 26th, 2026

Northwest Natural Holding Company (NWN) 8-K Filing: Company Information, Address, and SEC Details (March 23, 2026)

  • Capital Structure and Financial Metrics
    • Approved capital structure for each year: 50.0% long-term debt and 50.0% common equity.
    • Return on Equity (ROE): Fixed at 9.5% for all three years.
    • Cost of Long-Term Debt:
      • Year 1: 4.806%
      • Year 2: 4.863%
      • Year 3: 4.936%
    • Overall Rate of Return:
      • Year 1: 7.15%
      • Year 2: 7.18%
      • Year 3: 7.22%
    • Average Rate Base:
      • Year 1: \$328.0 million
      • Year 2: \$369.6 million
      • Year 3: \$410.7 million

      Note: The Year 1 rate base represents an increase of \$80.7 million since the last rate case.

    These metrics are critical for understanding the Company’s regulated earnings capacity and the impact of approved rates on both equity and debt holders.

  • Trading Information
    • Common Stock Trading Symbol: NWN
    • Exchange: New York Stock Exchange (NYSE)
  • View Northwest Natural Holding Co Historical chart here



    Gyre Therapeutics Acquires Cullgen Inc. in $300 Million All-Stock Merger to Advance Biopharmaceutical Innovation

    Cullgen Inc. Releases 2025 Annual and Q1 2026 Financial Resu...

    Driven Brands Holdings Inc. Reports Q1 2026 Financial Results and Business Highlights

    Driven Brands Holdings Inc. Reports Q1 2026 Results: Key Hig...

    Immunic, Inc. Announces 1-for-10 Reverse Stock Split Effective April 27, 2026

    Immunic, Inc. Announces 1-for-10 Reverse Stock Split: Key In...